EverHint – Momentum Swing Pack – Top 7 Signals for Nov 12, 2026
Excerpt: 7 signals. Healthcare leads (6). price range $39-$267. 1 with insider selling.
Breakout Standard
Stocks within 3% of 52-week high - standard breakout momentum setups. Stock showing strong momentum near or at highs. Increased volume confirms institutional interest. Breaking out or consolidating near resistance.
Entry Criteria:
- Strong RSI momentum
- Volume surge above average
- Within 3% of 52-week high
- Minimum ADV: $25M+
- Earnings buffer: 7 days
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (2 of 2)
Ranked by composite momentum score
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | SMA | Smartstop Self Storage... | Real Estate | $39.33 | 0.30 | — | $2.2B |
| 2 | ASND | Ascendis Pharma A/S | Healthcare | $267.07 | 0.00 | — | $17.6B |
Sector Healthcare
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (1 of 1)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | Healthcare | $267.07 | 0.00 | — | $17.6B |
Breakout Ultra Tight
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (1 of 1)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | Healthcare | $267.07 | 0.00 | — | $17.6B |
Quality Low Vol
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (1 of 1)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | Healthcare | $267.07 | 0.00 | — | $17.6B |
Cap Large Only
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (1 of 1)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | ASND | Ascendis Pharma A/S | Healthcare | $267.07 | 0.00 | — | $17.6B |
Volatile High Beta
High momentum stock screener for swing trading opportunities. Identifies stocks with strong momentum characteristics suitable for swing trading (1-4 week holds). Includes multiple variants: breakout, pullback, aggressive momentum, and volatile high-beta.
Entry Criteria:
- Strong RSI momentum (configurable thresholds)
- Volume surge above average
- Price momentum confirmation
- Minimum ADV: $25M+ (varies by variant)
- Earnings buffer: 7 days pre/post earnings
- Variant-specific filters applied
Holding period: 1-4 weeks | Risk level: Medium-High
📊 Signals (1 of 1)
Ranked by composite momentum score (higher = stronger momentum)
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | HTFL | Heartflow, Inc. Common... | Healthcare | $59.92 | 0.00 | Sell -$2,358,935 | $5.2B |
Insider selling (7d): HTFL (-$2,358,935)
Recent Headlines
ASND (Ascendis Pharma A/S)
- Ascendis Pharma A/S Q3 Earnings Call Highlights
- Ascendis Pharma A/S (ASND) Q3 2026 Earnings Call Transcript
- Ascendis Pharma Reports Third Quarter 2026 Financial Results
- Ascendis Pharma AS ADR earnings beat by €0.28, revenue topped estimates
- Ascendis Pharma stock rises 2% on beating estimates as product sales surge 89%
- Ascendis Pharma to Participate in the Jefferies London Healthcare Conference
HTFL (Heartflow, Inc. Common Stock)
- HeartFlow (HTFL) Reports Q3 Loss, Beats Revenue Estimates
- Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
- Voya Small Cap Growth Strategy Q3 2026 Contributors And Detractors
SMA (Smartstop Self Storage REIT Inc)
- 18,566 Shares in Smartstop Self Storage REIT Inc $SMA Bought by CenterBook Partners LP
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.